Pharmacokinetic and pharmacodynamic principles: unique considerations for optimal design of neonatal clinical trials

被引：0
|
作者：
Yeung, Cindy Hoi Ting [1 ]
Verstegen, Ruud H. J. [1 ,2 ]
Greenberg, Rachel [3 ,4 ]
Lewis, Tamorah Rae [1 ,2 ]
机构：
[1] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON, Canada
[2] Univ Toronto, Dept Pediat, Toronto, ON, Canada
[3] Duke Clin Res Inst, Durham, NC USA
[4] Duke Univ, Sch Med, Dept Pediat, Durham, NC USA
来源：
FRONTIERS IN PEDIATRICS | 2024年 / 11卷
关键词：
neonate; clinical trial; pharmacokinetic; pharmacogenetic; dose; pharmacodynamic; PATENT DUCTUS-ARTERIOSUS; THERAPEUTIC INDEX; DEVELOPMENTAL-CHANGES; INFANTS; SIMULATION; CHILDREN; DRUGS; AGE;
D O I：
10.3389/fped.2023.1345969
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Core clinical pharmacology principles must be considered when designing and executing neonatal clinical trials. In this review, the authors discuss important aspects of drug dose selection, pharmacokinetics, pharmacogenetics and pharmacodynamics that stakeholders may consider when undertaking a neonatal or infant clinical trial.
引用
收藏
页数：11
相关论文
共 50 条
  • [41] Use of a Pharmacokinetic/Pharmacodynamic Model to Design an Optimal Dose Input Profile
    Kyungsoo Park
    Davide Verotta
    Suneel K. Gupta
    Lewis B. Sheiner
    [J]. Journal of Pharmacokinetics and Biopharmaceutics, 1998, 26 : 471 - 492
  • [42] Use of Pharmacokinetic and Pharmacodynamic Knowledge of Bilastine for the Optimal Design of the First Pediatric Trial
    Vozmediano, Valvanera
    Lukas, John C.
    Rodriguez, Monica
    Valiente, Roman
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S107 - S107
  • [43] Optimal design for multiresponse pharmacokinetic-pharmacodynamic models - Dealing with unbalanced designs
    Ogungbenro, Kayode
    Gueorguieva, Ivelina
    Majid, Oneeb
    Graham, Gordon
    Aarons, Leon
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2007, 34 (03) : 313 - 331
  • [44] Ethical Considerations in Adaptive Design Clinical Trials
    Thomas Laage
    John W. Loewy
    Sandeep Menon
    Eva R. Miller
    Erik Pulkstenis
    Natalia Kan-Dobrosky
    Christopher Coffey
    [J]. Therapeutic Innovation & Regulatory Science, 2017, 51 : 190 - 199
  • [45] Ethical Considerations in Adaptive Design Clinical Trials
    Laage, Thomas
    Loewy, John W.
    Menon, Sandeep
    Miller, Eva R.
    Pulkstenis, Erik
    Kan-Dobrosky, Natalia
    Coffey, Christopher
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2017, 51 (02) : 190 - 199
  • [46] Considerations in the Design of Clinical Trials for Cognitive Aging
    Reiman, Eric M.
    Brinton, Roberta Diaz
    Katz, Russell
    Petersen, Ronald C.
    Negash, Selam
    Mungas, Dan
    Aisen, Paul S.
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2012, 67 (07): : 766 - 772
  • [47] RADIOBIOLOGICAL CONSIDERATIONS IN THE DESIGN OF CLINICAL-TRIALS
    BENTZEN, SM
    [J]. RADIOTHERAPY AND ONCOLOGY, 1994, 32 (01) : 1 - 11
  • [48] STATISTICAL AND ETHICAL CONSIDERATIONS IN DESIGN OF CLINICAL TRIALS
    GEHAN, EA
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1974, 100 (06) : 527 - 527
  • [49] Multiplicity considerations in the design and analysis of clinical trials
    Cook, RJ
    Farewell, VT
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 1996, 159 : 93 - 110
  • [50] Study design considerations in clinical trials with marihuana
    Jones, RT
    [J]. MARIHUANA AND MEDICINE, 1999, : 145 - 151
12345